August 31, 2023
FOx BIOSYSTEMS appoints Dr. Mark Truesdale as CEO
Diepenbeek, Belgium, September 1, 2023 – FOx BIOSYSTEMS, a dynamic company on a mission to…
March 20, 2023
STEVEN LAUWERS JOINS AS COO
Diepenbeek, Belgium, March 20, 2023 – FOx BIOSYSTEMS welcomes Steven Lauwers to its executive team…
January 13, 2023
FOx BIOSYSTEMS raises € 5.8 million in B-round financing to scale up its operations.
Diepenbeek, Belgium, January 13th, 2023 – Fox BIOSYSTEMS announces today that they successfully closed on…
December 20, 2022
FOx BIOSYSTEMS receives €2.5 million EIC grant to accelerate the market introduction of unique EV analysis and isolation application.
Diepenbeek, Belgium, December 20th, 2022 – FOx BIOSYSTEMS is awarded an EIC accelerator grant for…
February 10, 2022
International Day of Women & Girls in Science, 11 February
Hear from some of our amazing female colleagues for the International Day of Women and…
January 28, 2022
Innovative FO-SPR Label-free Strategy for Detecting Anti-RBD Antibodies in COVID-19 Patient Serum and Whole Blood
The latest publication from the Biosensor Group at KU Leuven presents the use of fiber-optic…
August 24, 2021
Gold nanoparticle enhanced multiplexed biosensing on a fiber optic surface plasmon resonance probe
A new study from the Biosensor Group at KU Leuven demonstrates that our White FOx instrument…
March 18, 2021
FOx BIOSYSTEMS launches the WHITE FOxTM, its new generation biosensor with fiber-optic surface plasmon resonance
Press release The White FOx brings maximum flexibility, control and insight to diagnostic development, life…